Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. Porter'S Five Force Analysis
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. High Prevalence of Influenza
3.4.1.2. Increase In Government Focus On Immunization Programs
3.4.1.3. Emerging Vaccines
3.4.1.4. Technological Progress In Vaccine Administration

3.4.2. Restraints

3.4.2.1. Longer Timelines And Implementation of Stringent Regulations
3.4.2.2. High Costs Associated With The Development of Vaccines

3.4.3. Opportunity

3.4.3.1. High Growth Prospects In Emerging Markets

Chapter 4: Influenza Vaccine Market, By Vaccine Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Quadrivalent

4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country

4.3. Trivalent

4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country

Chapter 5: Influenza Vaccine Market, By Type

5.1. Overview
5.2. Seasonal Influenza Vaccine
5.3. Pandemic Influenza Vaccine

Chapter 6: Influenza Vaccine Market, By Technology

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Egg-Based

6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country

6.3. Cell Culture

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country

Chapter 7: Influenza Vaccine Market, By Age Group

7.1. Overview

7.1.1. Market Size And Forecast

7.2. Pediatric

7.2.1. Market Size And Forecast, By Region
7.2.2. Market Analysis, By Country

7.3. Adult

7.3.1. Market Size And Forecast, By Region
7.3.2. Market Analysis, By Country

Chapter 8: Influenza Vaccine Market, By Route of Administration

8.1. Overview

8.1.1. Market Size And Forecast

8.2. Injection

8.2.1. Market Size And Forecast
8.2.2. Market Analysis, By Country

8.3. Nasal Spray

8.3.1. Market Size And Forecast
8.3.2. Market Analysis, By Country

Chapter 9: Global Influenza Vaccine Market, By Region

9.1. Overview

9.1.1. Market Size And Forecast

9.2. North America

9.2.1. Key Market Trends And Opportunities
9.2.2. Market Size And Forecast, By Vaccine Type
9.2.3. Market Size And Forecast, By Technology
9.2.4. Market Size And Forecast, By Age Group
9.2.5. Market Size And Forecast, By Route of Administration
9.2.6. Market Size And Forecast, By Country

9.2.6.1. U.S. Market Size And Forecast, By Vaccine Type
9.2.6.2. U.S. Market Size And Forecast, By Technology
9.2.6.3. U.S. Market Size And Forecast, By Age Group
9.2.6.4. U.S. Market Size And Forecast, By Route of Administration
9.2.6.5. Canada Market Size And Forecast, By Vaccine Type
9.2.6.6. Canada Market Size And Forecast, By Technology
9.2.6.7. Canada Market Size And Forecast, By Age Group
9.2.6.8. Canada Market Size And Forecast, By Route of Administration
9.2.6.9. Mexico Market Size And Forecast, By Vaccine Type
9.2.6.10. Mexico Market Size And Forecast, By Technology
9.2.6.11. Mexico Market Size And Forecast, By Age Group
9.2.6.12. Mexico Market Size And Forecast, By Route of Administration

9.3. Europe

9.3.1. Key Market Trends And Opportunities
9.3.2. Market Size And Forecast, By Vaccine Type
9.3.3. Market Size And Forecast, By Technology
9.3.4. Market Size And Forecast, By Age Group
9.3.5. Market Size And Forecast, By Route of Administration
9.3.6. Market Size And Forecast, By Country

9.3.6.1. Germany Market Size And Forecast, By Vaccine Type
9.3.6.2. Germany Market Size And Forecast, By Technology
9.3.6.3. Germany Market Size And Forecast, By Age Group
9.3.6.4. Germany Market Size And Forecast, By Route of Administration
9.3.6.5. France Market Size And Forecast, By Vaccine Type
9.3.6.6. France Market Size And Forecast, By Technology
9.3.6.7. France Market Size And Forecast, By Age Group
9.3.6.8. France Market Size And Forecast, By Route of Administration
9.3.6.9. Uk Market Size And Forecast, By Vaccine Type
9.3.6.10. Uk Market Size And Forecast, By Technology
9.3.6.11. Uk Market Size And Forecast, By Age Group
9.3.6.12. Uk Market Size And Forecast, By Route of Administration
9.3.6.13. Italy Market Size And Forecast, By Vaccine Type
9.3.6.14. Italy Market Size And Forecast, By Technology
9.3.6.15. Italy Market Size And Forecast, By Age Group
9.3.6.16. Italy Market Size And Forecast, By Route of Administration
9.3.6.17. Spain Market Size And Forecast, By Vaccine Type
9.3.6.18. Spain Market Size And Forecast, By Technology
9.3.6.19. Spain Market Size And Forecast, By Age Group
9.3.6.20. Spain Market Size And Forecast, By Route of Administration
9.3.6.21. Rest of Europe Market Size And Forecast, By Vaccine Type
9.3.6.22. Rest of Europe Market Size And Forecast, By Technology
9.3.6.23. Rest of Europe Market Size And Forecast, By Age Group
9.3.6.24. Rest of Europe Market Size And Forecast, By Route of Administration

9.4. Asia-Pacific

9.4.1. Key Market Trends And Opportunities
9.4.2. Market Size And Forecast, By Vaccine Type
9.4.3. Market Size And Forecast, By Technology
9.4.4. Market Size And Forecast, By Age Group
9.4.5. Market Size And Forecast, By Route of Administration
9.4.6. Market Size And Forecast, By Country

9.4.6.1. Japan Market Size And Forecast, By Vaccine Type
9.4.6.2. Japan Market Size And Forecast, By Technology
9.4.6.3. Japan Market Size And Forecast, By Age Group
9.4.6.4. Japan Market Size And Forecast, By Route of Administration
9.4.6.5. China Market Size And Forecast, By Vaccine Type
9.4.6.6. China Market Size And Forecast, By Technology
9.4.6.7. China Market Size And Forecast, By Age Group
9.4.6.8. China Market Size And Forecast, By Route of Administration
9.4.6.9. India Market Size And Forecast, By Vaccine Type
9.4.6.10. India Market Size And Forecast, By Technology
9.4.6.11. India Market Size And Forecast, By Age Group
9.4.6.12. India Market Size And Forecast, By Route of Administration
9.4.6.13. Australia Market Size And Forecast, By Vaccine Type
9.4.6.14. Australia Market Size And Forecast, By Technology
9.4.6.15. Australia Market Size And Forecast, By Age Group
9.4.6.16. Australia Market Size And Forecast, By Route of Administration
9.4.6.17. South Korea Market Size And Forecast, By Vaccine Type
9.4.6.18. South Korea Market Size And Forecast, By Technology
9.4.6.19. South Korea Market Size And Forecast, By Age Group
9.4.6.20. South Korea Market Size And Forecast, By Route of Administration
9.4.6.21. Rest of Asia-Pacific Market Size And Forecast, By Vaccine Type
9.4.6.22. Rest of Asia-Pacific Market Size And Forecast, By Technology
9.4.6.23. Rest of Asia-Pacific Market Size And Forecast, By Age Group
9.4.6.24. Rest of Asia-Pacific Market Size And Forecast, By Route of Administration

9.5. Lamea

9.5.1. Key Market Trends And Opportunities
9.5.2. Market Size And Forecast, By Vaccine Type
9.5.3. Market Size And Forecast, By Technology
9.5.4. Market Size And Forecast, By Age Group
9.5.5. Market Size And Forecast, By Route of Administration
9.5.6. Market Size And Forecast, By Country

9.5.6.1. Brazil Market Size And Forecast, By Vaccine Type
9.5.6.2. Brazil Market Size And Forecast, By Technology
9.5.6.3. Brazil Market Size And Forecast, By Age Group
9.5.6.4. Brazil Market Size And Forecast, By Route of Administration
9.5.6.5. Saudi Market Size And Forecast, By Vaccine Type
9.5.6.6. Saudi Market Size And Forecast, By Technology
9.5.6.7. Saudi Market Size And Forecast, By Age Group
9.5.6.8. Saudi Market Size And Forecast, By Route of Administration
9.5.6.9. South Africa Market Size And Forecast, By Vaccine Type
9.5.6.10. South Africa Market Size And Forecast, By Technology
9.5.6.11. South Africa Market Size And Forecast, By Age Group
9.5.6.12. South Africa Market Size And Forecast, By Route of Administration
9.5.6.13. Rest of Lamea Market Size And Forecast, By Vaccine Type
9.5.6.14. Rest of Lamea Market Size And Forecast, By Technology
9.5.6.15. Rest of Lamea Market Size And Forecast, By Age Group
9.5.6.16. Rest of Lamea Market Size And Forecast, By Route of Administration

Chapter 10: Company Profiles

10.1. Astrazeneca Plc (Astrazeneca)

10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Operating Business Segments
10.1.4. Product Portfolio
10.1.5. Business Performance

10.2. Biodiem

10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Operating Business Segments
10.2.4. Product Portfolio
10.2.5. Business Performance

10.3. Csl Limited (Seqirus Gmbh)

10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Operating Business Segments
10.3.4. Product Portfolio
10.3.5. Business Performance
10.3.6. Key Strategic Moves And Developments

10.4. Emergent Biosolutions

10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Operating Business Segments
10.4.4. Product Portfolio
10.4.5. Business Performance

10.5. F. Hoffmann-La Roche Ltd.

10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Operating Business Segments
10.5.4. Product Portfolio
10.5.5. Business Performance

10.6. Gamma Vaccines Pty Ltd.

10.6.1. Company Overview
10.6.2. Company Snapshot
10.6.3. Operating Business Segments
10.6.4. Product Portfolio

10.7. Glaxosmithkline Plc

10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Operating Business Segments
10.7.4. Product Portfolio
10.7.5. Business Performance
10.7.6. Key Strategic Moves And Developments

10.8. Merck & Co., Inc. (Merck Sharp & Dohme Corp.)

10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Operating Business Segments
10.8.4. Product Portfolio
10.8.5. Business Performance

10.9. Novartis Ag

10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Operating Business Segments
10.9.4. Product Portfolio
10.9.5. Business Performance

10.10. Pfizer, Inc.

10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.3. Operating Business Segments
10.10.4. Product Portfolio
10.10.5. Business Performance
10.10.6. Key Strategic Moves And Developments

10.11. Sanofi

10.11.1. Company Overview
10.11.2. Company Snapshot
10.11.3. Operating Business Segments
10.11.4. Product Portfolio
10.11.5. Business Performance

10.12. Sinovac Biotech Ltd.

10.12.1. Company Overview
10.12.2. Company Snapshot
10.12.3. Operating Business Segments
10.12.4. Product Portfolio
10.12.5. Business Performance